These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28921828)

  • 1. [HDL-C/apoA-I]: A multivessel cardiometabolic risk marker in women with T2DM.
    Hermans MP; Valensi P; Ahn SA; Rousseau MF
    Diabetes Metab Res Rev; 2018 Jan; 34(1):. PubMed ID: 28921828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Size, density and cholesterol load of HDL predict microangiopathy, coronary artery disease and β-cell function in men with T2DM.
    Hermans MP; Amoussou-Guenou KD; Bouenizabila E; Sadikot SS; Ahn SA; Rousseau MF
    Diabetes Metab Syndr; 2017; 11(2):125-131. PubMed ID: 27665027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different relationship between ANGPTL3 and HDL components in female non-diabetic subjects and type-2 diabetic patients.
    Zhao D; Yang LY; Wang XH; Yuan SS; Yu CG; Wang ZW; Lang JN; Feng YM
    Cardiovasc Diabetol; 2016 Sep; 15(1):132. PubMed ID: 27620179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low HDL-C/ApoA-I index is associated with cardiometabolic risk factors and coronary artery calcium: a sub-analysis of the genetics of atherosclerotic disease (GEA) study.
    Cardoso-Saldaña GC; Antonio-Villa NE; Martínez-Alvarado MDR; González-Salazar MDC; Posadas-Sánchez R
    BMC Endocr Disord; 2024 Jul; 24(1):110. PubMed ID: 38987727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDL cholesterol efflux normalised to apoA-I is associated with future development of type 2 diabetes: from the CORDIOPREV trial.
    Blanco-Rojo R; Perez-Martinez P; Lopez-Moreno J; Martinez-Botas J; Delgado-Lista J; van-Ommen B; Yubero-Serrano E; Camargo A; Ordovas JM; Perez-Jimenez F; Gomez-Coronado D; Lopez-Miranda J
    Sci Rep; 2017 Oct; 7(1):12499. PubMed ID: 28970513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of high-density lipoprotein cholesterol to apolipoprotein A-I and A-II to predict coronary calcium and the effect of insulin resistance.
    Martin SS; Qasim AN; Wolfe M; St Clair C; Schwartz S; Iqbal N; Schutta M; Bagheri R; Mehta NN; Rader DJ; Reilly MP
    Am J Cardiol; 2011 Feb; 107(3):393-8. PubMed ID: 21257004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HDL-C/apoA-I Ratio Is Associated with the Severity of Coronary Artery Stenosis in Diabetic Patients with Acute Coronary Syndrome.
    Sun L; Guo M; Xu C; Qiao X; Hua Y; Tuerhongjiang G; Lou B; Li R; Bai X; Zhou J; Wu Y; She J; Yuan Z
    Dis Markers; 2021; 2021():6689056. PubMed ID: 34055102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies.
    van der Steeg WA; Holme I; Boekholdt SM; Larsen ML; Lindahl C; Stroes ES; Tikkanen MJ; Wareham NJ; Faergeman O; Olsson AG; Pedersen TR; Khaw KT; Kastelein JJ
    J Am Coll Cardiol; 2008 Feb; 51(6):634-42. PubMed ID: 18261682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-apolipoprotein A-1 autoantibodies as risk biomarker for cardiovascular diseases in type 2 diabetes mellitus.
    El-Lebedy D; Rasheed E; Kafoury M; Abd-El Haleem D; Awadallah E; Ashmawy I
    J Diabetes Complications; 2016; 30(4):580-5. PubMed ID: 26965796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The HDL cholesterol/apolipoprotein A-I ratio: an indicator of cardiovascular disease.
    Rhee EJ; Byrne CD; Sung KC
    Curr Opin Endocrinol Diabetes Obes; 2017 Apr; 24(2):148-153. PubMed ID: 28099205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDL-C and HDL-C/ApoA-I predict long-term progression of glycemia in established type 2 diabetes.
    Waldman B; Jenkins AJ; Davis TM; Taskinen MR; Scott R; O'Connell RL; Gebski VJ; Ng MK; Keech AC;
    Diabetes Care; 2014 Aug; 37(8):2351-8. PubMed ID: 24804699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crossing family histories of diabetes and cardiovascular disease leads to unexpected outcomes in diabetic offspring.
    Hermans MP; Ahn SA; Rousseau MF
    J Diabetes; 2019 Apr; 11(4):301-308. PubMed ID: 30105804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of high-density lipoprotein cholesterol:apolipoprotein a-I ratio to progression of coronary atherosclerosis in statin-treated patients.
    Mani P; Uno K; St John J; Tuzcu EM; Nissen SE; Nicholls SJ
    Am J Cardiol; 2014 Sep; 114(5):681-5. PubMed ID: 25030535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of HDL cholesterol and estimates of HDL particle composition in future development of type 2 diabetes in the general population: the PREVEND study.
    Abbasi A; Corpeleijn E; Gansevoort RT; Gans RO; Hillege HL; Stolk RP; Navis G; Bakker SJ; Dullaart RP
    J Clin Endocrinol Metab; 2013 Aug; 98(8):E1352-9. PubMed ID: 23690306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort.
    Mariosa D; Hammar N; Malmström H; Ingre C; Jungner I; Ye W; Fang F; Walldius G
    Ann Neurol; 2017 May; 81(5):718-728. PubMed ID: 28437840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.
    Walldius G; Jungner I; Aastveit AH; Holme I; Furberg CD; Sniderman AD
    Clin Chem Lab Med; 2004; 42(12):1355-63. PubMed ID: 15576296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio.
    Kappelle PJ; Gansevoort RT; Hillege HJ; Wolffenbuttel BH; Dullaart RP;
    J Clin Lipidol; 2013; 7(1):56-64. PubMed ID: 23351584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ratio of HDL-C to apoA-I interacts with free triiodothyronine to modulate coronary artery disease risk.
    Li L; Cai G; Lu W; Li F; Yu L; Xiao J
    BMC Cardiovasc Disord; 2021 Oct; 21(1):504. PubMed ID: 34666674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of niacin on high-density lipoprotein apolipoprotein A-I kinetics in statin-treated patients with type 2 diabetes mellitus.
    Pang J; Chan DC; Hamilton SJ; Tenneti VS; Watts GF; Barrett PH
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):427-32. PubMed ID: 24285582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of apolipoprotein B/apolipoprotein A-I ratio with pre-diabetes and diabetes risks: a cross-sectional study in Chinese adults.
    Zheng S; Han T; Xu H; Zhou H; Ren X; Wu P; Zheng J; Wang L; Zhang M; Jiang Y; Chen Y; Qiu H; Liu W; Hu Y
    BMJ Open; 2017 Jan; 7(1):e014038. PubMed ID: 28110289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.